ArticleInvestigational new drugs2014

A phase I trial of bortezomib in combination with epirubicin, carboplatin and capecitabine (ECarboX) in advanced oesophagogastric adenocarcinoma.

R C Turkington et al.PubMed ↗Publisher ↗

No numbers read from the abstract.